As a leading publisher for regulatory professionals, RAPS is always interested in new manuscripts. Whether your idea involves prescription drugs, generics, over-the-counter products, biologics, ...

I appreciate the designation but sort of reject it, only because of my own philosophical stance, which is that it’s very hard ...